Indaptus Therapeutics, Inc. financial data

Symbol
INDP on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 Columbus Circle, 15 Th Floor, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Intec Parent Inc. (to 8/3/2021)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 695 % -27.2%
Debt-to-equity 16.5 % +43.2%
Return On Equity -108 % -84.5%
Return On Assets -92.9 % -76.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.54M shares +1.64%
Common Stock, Shares, Outstanding 8.54M shares +1.64%
Entity Public Float 13.3M USD -11.9%
Common Stock, Value, Issued 85.4K USD +1.64%
Weighted Average Number of Shares Outstanding, Basic 8.44M shares +0.49%
Weighted Average Number of Shares Outstanding, Diluted 8.44M shares +0.49%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.33M USD +6.16%
General and Administrative Expense 8.53M USD -5.77%
Operating Income (Loss) -15.9M USD +0.61%
Nonoperating Income (Expense) 890K USD +18.1%
Income Tax Expense (Benefit) 2.45K USD +8067%
Net Income (Loss) Attributable to Parent -15M USD +1.54%
Earnings Per Share, Basic -1.77 USD/shares +3.28%
Earnings Per Share, Diluted -1.77 USD/shares +11.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.74M USD +43.2%
Marketable Securities, Current 6.99M USD -62.7%
Assets, Current 10.3M USD -53.5%
Property, Plant and Equipment, Net 735 USD -63.6%
Operating Lease, Right-of-Use Asset 151K USD -36.1%
Other Assets, Noncurrent 505K USD -33.1%
Assets 10.9M USD -52.7%
Accounts Payable, Current 405K USD +6.11%
Employee-related Liabilities, Current 374K USD -12.9%
Liabilities, Current 1.54M USD -15.6%
Operating Lease, Liability, Noncurrent 50.7K USD -62.9%
Liabilities 1.59M USD -18.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 134K USD
Retained Earnings (Accumulated Deficit) -49.2M USD -43.7%
Stockholders' Equity Attributable to Parent 9.36M USD -55.8%
Liabilities and Equity 10.9M USD -52.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.94M USD +20.7%
Net Cash Provided by (Used in) Financing Activities 316K USD
Net Cash Provided by (Used in) Investing Activities 17.1M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 8.54M shares +1.64%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 54.5M USD +4.83%
Deferred Tax Assets, Gross 54.5M USD +4.86%
Operating Lease, Liability 153K USD -35.3%
Depreciation 735 USD +129%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.2M USD -0.87%
Lessee, Operating Lease, Liability, to be Paid 163K USD -37.9%
Operating Lease, Liability, Current 102K USD +2.63%
Lessee, Operating Lease, Liability, to be Paid, Year Two 86.9K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 86.9K USD +16.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.1K USD -61.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 86.9K USD
Deferred Tax Assets, Operating Loss Carryforwards 51.8M USD +3.19%
Operating Lease, Payments 25.3K USD +2.36%
Additional Paid in Capital 58.5M USD +6.03%
Share-based Payment Arrangement, Expense 2.32M USD +3965%